PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.68M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
56.44%
Some net income increase while CRK is negative at -34.01%. John Neff would see a short-term edge over the struggling competitor.
-5.86%
Negative yoy D&A while CRK is 30.36%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
26.83%
Some yoy growth while CRK is negative at -36.27%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-211.41%
Negative yoy working capital usage while CRK is 154.98%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
41.11%
Lower 'other non-cash' growth vs. CRK's 875.67%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
32.55%
Operating cash flow growth similar to CRK's 30.18%. Walter Schloss would see parallel improvements or market conditions in cash generation.
5.61%
Some CapEx rise while CRK is negative at -143.92%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
109.11%
Growth of 109.11% while CRK is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
92.75%
We have mild expansions while CRK is negative at -162.31%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
68.49%
Debt repayment growth of 68.49% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-31.09%
Both yoy lines negative, with CRK at -15.75%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
103.42%
Buyback growth of 103.42% while CRK is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.